Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tryptase inhibitors: a patent review
Wei‐Wei Ni, Mengda Cao, Wen Huang, et al.
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 8, pp. 919-928
Closed Access | Times Cited: 19

Showing 19 citing articles:

Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling
Louis J. Dell’Italia, James F. Collawn, Carlos M. Ferrario
Circulation Research (2018) Vol. 122, Iss. 2, pp. 319-336
Open Access | Times Cited: 99
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context
Mannon Geindreau, Mélanie Bruchard, Frédérique Végran
Cancers (2022) Vol. 14, Iss. 10, pp. 2446-2446
Open Access | Times Cited: 68
Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson’s Disease
Duraisamy Kempuraj, Govindhasamy Pushpavathi Selvakumar, Smita Zaheer, et al.
Journal of Neuroimmune Pharmacology (2017) Vol. 13, Iss. 1, pp. 100-112
Open Access | Times Cited: 71
Tick Salivary Compounds for Targeted Immunomodulatory Therapy
Hajer Aounallah, Chaima Bensaoud, Youmna M’ghirbi, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 41
The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications
Xi Chen, Zhijie Xu, Shuangshuang Zeng, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 35
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma
Man Hu, Jörg Scheffel, Daniel Elieh Ali Komi, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4177-4197
Open Access | Times Cited: 9
Mast cell tryptase – Marker and maker of cardiovascular diseases
Mohammad Mohajeri, Petri T. Kovanen, Vanessa Bianconi, et al.
Pharmacology & Therapeutics (2019) Vol. 199, pp. 91-110
Closed Access | Times Cited: 26
Proteases in Pemphigoid Diseases
Sho Hiroyasu, Christopher T. Turner, Katlyn C. Richardson, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 25
Mast Cells Positive for c-Kit Receptor and Tryptase Correlate with Angiogenesis in Cancerous and Adjacent Normal Pancreatic Tissue
Michele Ammendola, Giuseppe Currò, Carmelo Laface, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 444-444
Open Access | Times Cited: 18
Airway tryptase levels inform the lack of clinical efficacy of the tryptase inhibitor MTPS9579A in asthma
Horace Rhee, Lindsay M. Henderson, Rebecca N. Bauer, et al.
Allergy (2024)
Open Access | Times Cited: 2
The mast cells - Cytokines axis in Autism Spectrum Disorder
Eleonora Kovacheva, Maria Gevezova, Michaël Maes, et al.
Neuropharmacology (2024) Vol. 249, pp. 109890-109890
Open Access | Times Cited: 1
Monocyclic β-Lactam: A Review on Synthesis and Potential Biological Activities of a Multitarget Core
Taíse Helena Oliveira Leite, Maurício Frota Saraiva, Alessandra C. Pinheiro, et al.
Mini-Reviews in Medicinal Chemistry (2020) Vol. 20, Iss. 16, pp. 1653-1682
Closed Access | Times Cited: 11
Mast Cell Tryptase and Implications for SARS-CoV-2 Pathogenesis
Negar Karimi, Solmaz Morovati, Lily Chan, et al.
BioMed (2021) Vol. 1, Iss. 2, pp. 136-149
Open Access | Times Cited: 9
Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles
Chai Xin Yu, Jian Wei Tan, Kamal Rullah, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 12978-12996
Open Access | Times Cited: 2
Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma
Emmanuel Oshiogwe Okwuofu, Audrey Chee Hui Yong, Jonathan Chee Woei Lim, et al.
Pharmacological Research (2022) Vol. 181, pp. 106280-106280
Closed Access | Times Cited: 4
A natural product biflavonoid scaffold with anti-tryptase activity
Nicholas F. Fazio, Michael H. Russell, Steven M. Flinders, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2020) Vol. 394, Iss. 1, pp. 107-115
Closed Access | Times Cited: 5
Synthesis of Peptide–Adenine Conjugates as a New Tool for Monitoring Protease Activity
Nicolas Masurier, Feryel Soualmia, Pierre Sanchez, et al.
European Journal of Organic Chemistry (2018) Vol. 2019, Iss. 1, pp. 176-183
Closed Access | Times Cited: 3
When alpha meets beta, mast cells get hyper
Michelle S. Ong, Vinay Tergaonkar
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 10, pp. 2229-2230
Open Access | Times Cited: 3
Insight parameter drug design for human beta-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of alpha-keto-[1,2,4]-oxadiazoles
Chai Xin Yu, Jian Wei Tan, Syahrul Imran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top